| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 17.453 | 49.498 | 92.412 | 110.531 | 147.737 |
| Total Income - EUR | - | - | - | - | - | 17.453 | 49.498 | 92.412 | 110.531 | 147.737 |
| Total Expenses - EUR | - | - | - | - | - | 3.539 | 15.871 | 15.062 | 14.886 | 23.502 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 13.914 | 33.627 | 77.350 | 95.645 | 124.235 |
| Net Profit/Loss - EUR | - | - | - | - | - | 13.417 | 33.142 | 76.444 | 94.562 | 119.892 |
| Employees | - | - | - | - | - | 0 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Ghelmene Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 1.095 |
| Current Assets | - | - | - | - | - | 13.708 | 34.921 | 77.685 | 96.079 | 129.568 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 10.562 | 31.126 | 72.798 | 73.683 | 89.400 |
| Cash | - | - | - | - | - | 3.146 | 3.796 | 4.888 | 22.396 | 40.168 |
| Shareholders Funds | - | - | - | - | - | 13.459 | 33.191 | 76.493 | 94.610 | 119.940 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 249 | 1.730 | 1.192 | 1.469 | 10.723 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ghelmene Med S.r.l.